July 1, 2019 Premium Formulary Exclusions & Preferred Specialty Prior Authorization Requirements
Therapeutic Category Excluded Medications Preferred Alternatives
ALLERGIC REACTIONS
epinephrine injection made by Mylan, Auvi-Q (0.15mg, 0.3mg), Epi-Pen JR Anaphylaxis Treatment Epinephrine injection 0.15mg made by Impax(M), Epi- Pen 0.3mg
ANALGESICS
celecoxib, diflunisal, etodolac, fenoprofen, flurbiprofen, ibuprofen, indomethacin, ketoprofen, Non-Steroidal Anti- Cambia ketorolac, meclofenamate, Inflammatory Agents meloxicam, nabumetone, naproxen, oxaprozin, piroxicam, sulindac, tolmetin
diclofenac, ibuprofen, Pain Sprix Nasal Spray meloxicam
ANTIBACTERIALS
Oral Antibiotics Doryx, Doryx MPC, Minolira doxycycline hyclate
(M) Co-branded product * Tier 3 preferred 1 Existing utilizers of these medications will be allowed to continue on therapy. Grandfathering will not be provided for any other excluded drugs. Therapeutic Category Excluded Medications Preferred Alternatives
ANTICONVULSANTS
Trokendi XR1 topiramate ER Seizure Disorders Oxtellar XR1 oxcarbazepine IR
ANTIMIGRAINES
amitriptyline, atenolol, divalproex sodium, nadolol, propranolol, CGRP agonists Ajovy timolol, topiramate, venlafaxine, Aimovig, Emgality
rizatriptan ODT, Serotonin Receptor Onzetra Xsail, Sumavel, Zembrace sumatriptan injection, Agonists Symtouch sumatriptan nasal spray, zolmitriptan ODT
ANTIPARKINSON AGENTS
Parkinson’s Disease Osmolex ER amantadine
ANTIVIRALS
Ledipasvir-Sofosbuvir (M), Sofosbuvir- Hepatitis-C drugs Epclusa, Harvoni, Mavyret Velpatasvir (M)
Please talk with your HIV drugs Atripla1 doctor about clinically appropriate options.
AUTONOMIC & CENTRAL NERVOUS SYSTEM
Interferon Beta Medications for Extavia1, Plegridy1 Avonex, Betaseron Multiple Sclerosis
hydromorphone HCl ER, morphine sulfate ER, Oral Long-Acting Arymo ER, Kadian, Nucynta ER, oxymorphone HCl ER, Opioid Analgesics Xtampza ER, Zohydro ER Embeda, Hysingla ER, OxyContin
(M) Co-branded product * Tier 3 preferred 1 Existing utilizers of these medications will be allowed to continue on therapy. Grandfathering will not be provided for any other excluded drugs. Therapeutic Category Excluded Medications Preferred Alternatives
codeine sulfate, hydromorphone HCl, Oral Short-Acting Nucynta morphine sulfate, Opioid Analgesics oxycodone HCl, oxymorphone HCl
Transmucosal Fentanyl Abstral, Fentora, Lazanda, Subsys fentanyl citrate lozenge Analgesics
CARDIOVASCULAR
Hypertension Kapspargo metoprolol ER
atorvastatin, fluvastatin, Cholesterol-Lowering lovastatin, pravastatin, Zypitamag Agents rosuvastatin, simvastatin, Livalo
CORTICOSTEROIDS
Oral Steroids Rayos prednisone
DERMATOLOGICAL AGENTS
Non-Steroidal Pennsaid diclofenac solution Anti-Inflammatory
adapalene, adapalene/ benzoyl peroxide, clindamycin gel/lotion/ Acanya, Aktipak, Clindagel solution, clindamycin/ Topical Acne Treatment Clindamycin phosphate 1% gel(M), benzoyl peroxide, Veltin erythromycin/benzoyl peroxide, tretinoin cream, Epiduo, Epiduo Forte, Onexton
Topical Anesthetics ZTlido lidocaine patch
Topical Antifungals Jublia terbinafine, Kerydin
metronidazole cream/gel/ Topical Antiinfective Noritate cream lotion, Soolantra
(M) Co-branded product * Tier 3 preferred 1 Existing utilizers of these medications will be allowed to continue on therapy. Grandfathering will not be provided for any other excluded drugs. Therapeutic Category Excluded Medications Preferred Alternatives
fluticasone ointment, Halog cream/ointment halobetasol cream/ ointment, triamcinolone Topical Corticosteroids betamethasone, Halobetasol foam (M), Lexette clobetasol, halobetasol cream/ointment
Topical Plaque Psoriasis Sorilux calcipotriene Treatment
DIABETES
Examples: Abbott (FreeStyle, Blood Glucose Meters, Precision), Arkray (Glucocard), Bayer Lifescan (One Touch Test Strips and Control (Breeze, Contour), Nipro (TRUEtest, products) Solutions TRUEtrack), Roche (Accu-Chek)
metformin HCl 24hr ER osmotic Blood Sugar Regulators metformin ER (generic release, metformin HCl 24hr ER Miscellaneous GLUCOPHAGE XR) modified release
Alogliptin(M), Alogliptin with Dipeptidyl Peptidase-4 Janumet, Janumet XR, metformin(M), Alogliptin with (DPP4) Inhibitors & Januvia, Jentadueto, pioglitazone(M), Kazano, Kombiglyze Combinations Jentadueto XR, Tradjenta XR, Nesina, Onglyza, Oseni
Basal insulin Basaglar, Levemir, Tresiba Lantus, Toujeo
Bydureon, Bydureon Glucagon-Like Peptide- Adlyxin, Tanzeum Bcise, Byetta, Ozempic, 1(GLP1) Agonists Trulicity, Victoza
Insulins Novolin Humulin
Rapid-acting insulin Admelog, Apidra, Fiasp, Novolog Humalog
Sodium-glucose Invokamet, Invokamet Farxiga, Segluromet, Steglatro, co-transporter (SGLT2) XR, Invokana, Jardiance, Xigduo XR Inhibitors Synjardy, Synjardy XR
SGLT2 and DPP4 Qtern, Steglujan Glyxambi Combinations
ENDOCRINE (OTHER)
Genotropin, Humatrope, Saizen, Norditropin, Nutropin, Growth Hormones Zomacton Omnitrope (M) Co-branded product * Tier 3 preferred 1 Existing utilizers of these medications will be allowed to continue on therapy. Grandfathering will not be provided for any other excluded drugs. Therapeutic Category Excluded Medications Preferred Alternatives
Infertility Bravelle, Follistim AQ Gonal-F
Nocturia Noctiva desmopressin, Nocdurna
GASTROINTESTINAL
diphenoxylate/atropine, Anti-Diarrheal Agents Motofen loperamide
granisetron solution/tablet, Antiemetics Sancuso patch ondansetron ODT
famotidine PLUS Anti-Inflammatory, Duexis, Vimovo ibuprofen, omeprazole Anti-Ulcer Agents PLUS naproxen Zorvolex ibuprofen, naproxen
Irritable Bowel Syndrome with Constipation/ Chronic Amitiza, Trulance Linzess Idiopathic Constipation (IBS-C/CIC)
Opioid-Induced Amitiza, Movantik, Relistor Symproic Constipation (OIC)
Inflammatory Bowel Delzicol, Dipentum balsalazide, Apriso Disease
Pancreatic Enzymes Pancreaze, Pertzye, Viokace Creon, Zenpep
esomeprazole magnesium delayed lansoprazole, omeprazole, Proton pump inhibitors release, omeprazole/ sodium pantoprazole bicarbonate cap/powder pak
HEMATOLOGICAL
Erythropoiesis-Stimulating Epogen Aranesp, Procrit, Retacrit Agents
Short-Acting Granulocyte- Colony Stimulating Factor Granix, Neupogen Nivestym, Zarxio (G-CSFs)
(M) Co-branded product * Tier 3 preferred 1 Existing utilizers of these medications will be allowed to continue on therapy. Grandfathering will not be provided for any other excluded drugs. Therapeutic Category Excluded Medications Preferred Alternatives
IMMUNOMODULATORS
Interleukin-17 (IL-17) Taltz1 Cosentyx*
JAK Inhibitor Olumiant1 Xeljanz, Xeljanz XR
OPHTHALMIC
latanoprost ophthalmic Antiglaucoma Drugs Rescula, Vyzulta, Zioptan solution, Lumigan, Travatan Z
Anti-Inflammatory Bromsite, Ilevro, Nevanac Prolensa
RESPIRATORY
COPD: Inhaled Seebri, Tudorza Incruse Ellipta, Spiriva Anticholinergics
COPD: Long-Acting Beta Agonist/Long-Acting Anoro Ellipta, Stiolto Bevespi, Utibron Muscarinic Agonist Respimat Combination inhalers
Cystic Fibrosis Kitabis Pak, TOBI Podhaler, Bethkis (inhaled tobramycin) Tobramycin Neb(M)
Alvesco, Armonair, Asmanex, Arnuity Ellipta, Flovent Pulmonary Anti- Asmanex HFA, QVAR, QVAR Diskus, Flovent HFA, Inflammatory Inhalers Redihaler Pulmicort Flexhaler
Pulmonary Anti- Advair Diskus, Advair Inflammatory , Long- AirDuo, Dulera HFA, Breo Ellipta, Acting Beta Agonist Symbicort Combination Inhalers
Short-Acting Beta-2 Levalbuterol Inhaler(M), Proventil ProAir HFA, ProAir Adrenergic Inhalers HFA, Xopenex HFA Respiclick Ventolin HFA
UROLOGICAL
Erectile Dysfunction Oral Stendra sildenafil Agents Excluded brand-name medications with generic equivalents
The brand-name medications below are excluded on the formulary. These brand-name medications have been identified as having available generic equivalents covered atTier 1 on the formulary. Speak with your pharmacist to have your excluded brand-name medication substituted with its generic equivalent. A generic medication contains the same active ingredient(s) as a brand-name medication. An active ingredient is what makes the medication work. For example, Liptor® and its generic both contain atorvastatin, which reduces the amount of bad cholesterol in the blood. Brand-name medications are often protected by a patent. When the patent ends, drug companies can apply to the U.S. Food and Drug Administration (FDA) to begin making generic versions of the medication.
Retin-A Micro Aciphex Celebrex Lialda Vytorin Gel 0.04%, 0.1%
Sabril Powder Acticlate Concerta Lidoderm Wellbutrin SR Pak
Sandostatin Aczone 5% Crestor Lipitor Wellbutrin XL Solution Injection
Adderall XR Cymbalta Lovaza Singulair Xanax
Alphagan P Cytomel Lunesta Staxyn Xanax XR 0.15%
Depo – Taclonex Ambien Testosterone Minastrin Yaz Ointment Injection
Dilantin Capsule Ambien CR Nasonex Tamiflu Capsule Zegerid 100mg
Dilantin Amrix Nexium Capsule Testim Zetia Chewable
Dilantin Androgel 1% Nitrostat TOBI Nebulizer Ziana Suspension
Tobradex Asacol HD Diovan Norco Zoloft Suspension
Ativan Diovan HCT Norvasc Topicort Spray Zomig
Axiron Duac Nuvigil Toprol XL Zomig ZMT Excluded brand-name medications with generic equivalents
Azor Duragesic Ortho Tri Cyclen Tribenzor
Ortho Tri Cyclen Benicar Effexor XR Vagifem Lo
Benicar HCT Fortamet Percocet Valium
Prevacid Zovirax oral, Benzaclin Fortesta Viagra Capsule ointment, suspension Benzamycin Glumetza Pristiq Vivelle-Dot
Beyaz Levitra Prozac Vogelxo
Pulmicort Carafate Lexapro Inhalation Voltaren Gel Suspension
Required Prior Authorization +
Therapeutic Class Non-Preferred Medications Preferred Medications
Lepidasvir- All other brands non-preferred with prior Sofosbuvir(M), Hepatitis C authorization Mavyret, Sofosbuvir- Velpatasvir(M), Vosevi
All other brands non-preferred with prior Avonex, Betaseron, Multiple Sclerosis authorization and Gilenya* Tier 3 with Copaxone, Tecfidera prior authorization
Cimzia, Humira, Otezla, All other brands non-preferred with Immunomodulators Simponi, Stelara, prior authorization Tremfya
+ All of the products listed above are currently subject to prior authorization. Preferred medications are required prior to new requests for non-preferred medication(s). Existing utilizers of non-preferred medication(s) within the therapeutic categories of Hepatitis C, Immunomodulators and Multiple Sclerosis will be eligible to remain on current therapy if compliance and efficacy of therapy are demonstrated. Exceptions will be granted for specific indications where the preferred agents do not have FDA-approval for use.
(M) Co-branded product
About this document: Where differences exist between this formulary and your benefit plan documents, the benefit plan documents rule. This may not be a complete list of medications, and not all medications listed may be covered by your plan. Please look at the benefit plan documents provided by your employer or plan sponsor for full details.
www.FutureScripts.com FutureScripts is a registered service mark of OptumRx, an Optum company. All other trademarks are the property of their respective owners. © 2019 FutureScripts. All rights reserved. WF1251689_ORX_FS_Premium formulary exclusions_05172019